NICE has approved Victoza 1.2mg as part of a triple therapy regimen with oral therapies metformin/sulphonylurea, but did not pass the higher 1.8mg dose, saying it showed only “marginal benefit”.
http://www.inpharm.com/news/victoza-wins-partial-nice-recommendation
Also, Novo Nordisk is reintroducing in Greece drugs for treating diabetes it had pulled from the Greek market over a government decree to lower drug prices.
Finally, mid-stage tests show Novo Nordisk's new-generation Degludec insulins are at least as effective as main rival Lantus...
http://www.iii.co.uk/shares/?type=news&articleid=7943393&action=article
http://www.inpharm.com/news/victoza-wins-partial-nice-recommendation
Also, Novo Nordisk is reintroducing in Greece drugs for treating diabetes it had pulled from the Greek market over a government decree to lower drug prices.
Finally, mid-stage tests show Novo Nordisk's new-generation Degludec insulins are at least as effective as main rival Lantus...
http://www.iii.co.uk/shares/?type=news&articleid=7943393&action=article
